Amedisys, Inc.
AMED
Rang in aandelen
#4616
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Aandeelprijs
$100.99
Laatst gesynchroniseerd: 2025-08-15
Marktkapitalisatie
$3.31B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Amedisys, Inc. (AMED)
Categorie
Healthcare
Omzet van Amedisys, Inc. (AMED)
Omzet in Jun 2025 TTM: $2.40B
Volgens de laatste financiële rapporten van Amedisys, Inc. bedraagt de huidige omzet van het bedrijf (TTM) $2.40B. In 2023 behaalde het bedrijf een omzet van $2.24B een stijging ten opzichte van de omzet in het jaar 2022, die $2.22B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Amedisys, Inc. van 2000 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $2.40B | 2.30% |
| 2024 | $2.35B | 5.01% |
| 2023 | $2.24B | 0.59% |
| 2022 | $2.22B | 0.41% |
| 2021 | $2.21B | 6.88% |
| 2020 | $2.07B | 5.93% |
| 2019 | $1.96B | 17.63% |
| 2018 | $1.66B | 8.40% |
| 2017 | $1.53B | 6.69% |
| 2016 | $1.44B | 12.25% |
| 2015 | $1.28B | 6.31% |
| 2014 | $1.20B | -3.59% |
| 2013 | $1.25B | -16.03% |
| 2012 | $1.49B | 1.19% |
| 2011 | $1.47B | -10.03% |
| 2010 | $1.63B | 7.99% |
| 2009 | $1.51B | 27.46% |
| 2008 | $1.19B | 70.13% |
| 2007 | $697.93M | 28.97% |
| 2006 | $541.15M | 41.83% |
| 2005 | $381.56M | 68.02% |
| 2004 | $227.09M | 59.39% |
| 2003 | $142.47M | 10.08% |
| 2002 | $129.42M | 17.47% |
| 2001 | $110.17M | 21.40% |
| 2000 | $90.76M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| $78.01B | 3,147.34% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 807.94% |
US
|
|
| $3.89B | 62.13% |
SA
|
|
| $11.08B | 361.42% |
BR
|
